HealthPolitics
STAT+: New Trump regulations would clean up health care pricing disclosures
Publication: STAT
Author: Bob Herman
Source published: 05/10/2026, 18:33:57 UTC
Briefing created: 21/10/2026, 10:04:53 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 06/10/2026, 14:37:24 UTC.
Briefings
The Trump administration released new regulations requiring health insurance companies to publish cleaned-up price spreadsheets for hospitals and doctors, removing meaningless data. They also announced plans to develop a system for disclosing prescription drug prices by next month, with a final plan expected by May 2026. Enforcement is scheduled for the end of 2027. Mehmet Oz, head of Medicare and Medicaid, confirmed these measures at an event on October 5, 2026.
Key points
- The Trump administration released new regulations requiring health insurance companies to publish cleaned-up price spreadsheets for hospitals and doctors, removing meaningless data.
- A final plan for drug pricing data disclosure is scheduled to be released by May 2026, with enforcement scheduled for the end of 2027.
Context
This finding addresses a long-standing policy gap where drug prices were not fully disclosed, allowing pharmaceutical companies to maintain high prices. The new rules aim to improve transparency in healthcare pricing, a key issue for consumers and policymakers.
Limitations
Enforcement is scheduled for the end of 2027, and the final drug pricing plan is expected by May 2026. The evidence does not specify the exact scope of 'meaningless data' removed or the specific impact on hospital and doctor pricing transparency.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 21/10/2026, 10:04:53 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeiaesysk4w7n3kzwjvhkdudw35baq2fhgiiskf7fvro5apmlxk7qc4